Related Articles |
Ultrasound mixed transcutaneous electrical nerve stimulation (UltraTENS) versus phonophoresis of piroxicam (PhP) in symptomatic knee osteoarthritis: A randomized double-blind, managed trial.
J Again Musculoskelet Rehabil. 2018 Feb 02;:
Authors: Boonhong J, Suntornpiyapan P
Summary
BACKGROUND: Ultrasound mixed with transcutaneous electrical nerve stimulation (UltraTENS) and phonophoresis of piroxicam (PhP) are mixed modality remedy that continuously utilized in musculoskeletal ache together with knee osteoarthritis (OA). However it’s lack of a very good medical trial to show and examine their results.
OBJECTIVE: To match the consequences of UltraTENS with PhP on delicate to reasonable diploma of symptomatic knee OA.
METHODS: Sixty-one sufferers (55 ladies), imply age of 63.four ± eight.1 y, 50-90 mm VAS of knee ache and Kellgren-Lawrence rating of grade I-III had been randomly allotted into UltraTENS and PhP (N = 31 and 30, respectively). The UltraTENS group acquired a mixed ultrasound with TENS program and a non-drug gel, whereas the PhP group acquired an ultrasound program with piroxicam gel and sham TENS. All sufferers had been handled for a complete of 10 classes, consisting of 5 occasions per week and 10 min per session. Earlier than and after remedy, sufferers had been evaluated knee ache through the use of the 100-mm VAS and useful efficiency by Western Ontario and McMaster Universities Osteoarthritis (WOMAC) index.
RESULTS: The UltraTENS and PhP teams skilled appreciable enchancment in each VAS and whole WOMAC scores post-treatment (P< zero.001). The PhP had higher VAS of ache and WOMAC scores however no statistical significance.
CONCLUSIONS: Outcomes present that UltraTENS and PhP had been efficient for relieving ache and enhance performance knee OA with out vital variations between their results.
PMID: 29439307 [PubMed – as supplied by publisher]